101. Trans10, cis12-conjugated linoleic acid exhibits a stronger antioxidant capacity than cis9, trans11-conjugated linoleic acid in primary cultures of laying hen hepatocytes
- Author
-
Hemin Ni, Guang-hai Qi, Ya-nan Zhang, Hongyuan Yue, Jing Wang, Yong Guo, Xiaolong Qi, Shu-geng Wu, and Hai-jun Zhang
- Subjects
0301 basic medicine ,Antioxidant ,medicine.medical_treatment ,Linoleic acid ,Conjugated linoleic acid ,Antioxidants ,Superoxide dismutase ,Linoleic Acid ,03 medical and health sciences ,chemistry.chemical_compound ,medicine ,Animals ,Linoleic Acids, Conjugated ,Cells, Cultured ,chemistry.chemical_classification ,Reactive oxygen species ,030109 nutrition & dietetics ,integumentary system ,biology ,Dose-Response Relationship, Drug ,food and beverages ,General Medicine ,Molecular biology ,Animal Feed ,Enzyme assay ,Diet ,030104 developmental biology ,Enzyme ,chemistry ,Catalase ,Dietary Supplements ,biology.protein ,Hepatocytes ,lipids (amino acids, peptides, and proteins) ,Animal Science and Zoology ,Female ,Chickens - Abstract
The objective of this study consisting of 2 trials was to investigate the antioxidant role of conjugated linoleic acid (CLA) isomers (c9, t11-CLA and t10, c12-CLA) and the underlying mechanism by which they act in modulating redox status in a primary laying hen hepatocyte culture. In trial 1, the cytotoxicity of CLA isomers or linoleic acid (LA) (0, 25, 50, 100, 200, 400, 800 μmol/L) was evaluated by 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT) assay. The concentration of CLA isomers or LA (25, 50, 100 μmol/L) for proper antioxidant activity was evaluated by measuring the antioxidant enzyme activity. In trial 2, there were 5 groups: control group, cells were untreated; H2O2 group, cells were exposed to 4 mmol/L H2O2 for 2 h; c9, t11 or t10, c12 or LA group, cells were treated with c9, t11-CLA or t10, c12-CLA or LA for 24 h and then exposed to 4 mmol/L H2O2 for 2 h. Trial 1 showed that the non-toxic dose range for CLA isomers was 0 to 200 μmol/L. The optimum concentration of c9, t11-CLA and t10, c12-CLA for trial 2 was 100 μmol/L. In trial 2, pretreatment with t10, c12-CLA but not c9, t11-CLA attenuated the increase in reactive oxygen species (ROS) compared to hydrogen peroxide (H2O2) group (P < 0.05). t10, c12-CLA elevated the superoxide dismutase (SOD) and catalase (CAT) activities compared with the H2O2 group (P < 0.05). In addition, t10, c12-CLA up-regulated the mRNA expression of nuclear factor E2-related factor-2 (Nrf2) as well as its target genes, Cu-Zn superoxide dismutase (SOD1) and CAT (P < 0.05). Pretreatment with t10, c12-CLA but not c9, t11-CLA decreased Nrf2 protein expression in the cytoplasm and increased Nrf2 protein expression in the nucleus compared with the H2O2 group (P < 0.05). The results indicate that t10, c12-CLA exhibits a stronger antioxidant capacity than c9, t11-CLA in primary cultured laying hen hepatocytes. t10, c12-CLA increases the activity and mRNA expression of antioxidant enzymes via facilitating nuclear translocation of Nrf2.
- Published
- 2018